NPS Pharmaceuticals Announces Completion Of Patient Randomization In Phase 3 STEPS StInformation on NPS Pharmaceuticals Announces Completion Of Patient Randomization In Phase 3 STEPS St under Bowel Disorders section of the Health Articles & Reviews; NPS Pharmaceuticals, a specialty pharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, announced the completion of patient randomization in its Phase 3 ... |
 |
|
NPS Pharmaceuticals Announces Completion Of Patient Randomization In Phase 3 STEPS St
by Ellen_Toon 07-25-2010, 01:10 PM
NPS Pharmaceuticals, a specialty pharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, announced the completion of patient randomization in its Phase 3 registration study of GATTEX (teduglutide). The double-blind, placebo-controlled safety and efficacy study, which is known as STEPS, is being conducted in patients with parenteral nutrition ...
More... |
Views 17
Comments 0
|
|
| Bookmarks |
| Currently Active Users Viewing This Article: 1 (0 members and 1 guests) | |
| Article Tools | |
| Display Modes | |
|
|
 |  |  |  |
 |  |  |  |
 |  |  |  |
 |  |  |  |
 |  |  |  |
Linear Mode
